CURIS, INC. Cash and Restricted Cash
CURIS, INC. (CRIS) had Cash and Restricted Cash of $5.62 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-14
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $5.62M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $15.54M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $5.61M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $9.60M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents as first filed |
|---|---|---|
| 2026-06-30 | $5.62M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $15.54M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $5.61M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $9.60M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $10.68M 10-Q · filed 2026-08-14 | |
| 2025-03-31 | $20.83M 10-Q · filed 2026-05-13 | |
| 2024-12-31 | $20.54M 10-Q · filed 2026-08-14 | |
| 2024-09-30 | $21.40M 10-Q · filed 2025-11-06 | |
| 2024-06-30 | $10.54M 10-Q · filed 2025-08-05 | |
| 2024-03-31 | $30.50M 10-Q · filed 2025-05-06 | |
| 2023-12-31 | $27.23M 10-K · filed 2026-03-24 | |
| 2023-09-30 | $25.01M 10-Q · filed 2024-11-14 | |
| 2023-06-30 | $20.46M 10-Q · filed 2024-08-01 | |
| 2023-03-31 | $32.33M 10-Q · filed 2024-05-07 | |
| 2022-12-31 | $20.29M 10-K · filed 2025-03-31 | |
| 2022-09-30 | $30.49M 10-Q · filed 2023-11-02 | |
| 2022-06-30 | $34.64M 10-Q · filed 2023-08-03 | |
| 2022-03-31 | $19.19M 10-Q · filed 2023-05-04 | |
| 2021-12-31 | $40.74M 10-K · filed 2024-02-08 | |
| 2021-09-30 | $53.75M 10-Q · filed 2022-11-09 | |
| 2021-06-30 | $75.84M 10-Q · filed 2022-08-04 | |
| 2021-03-31 | $111.85M 10-Q · filed 2022-05-05 | |
| 2020-12-31 | $130.43M 10-K · filed 2023-03-13 | |
| 2020-09-30 | $24.37M 10-Q · filed 2021-11-09 | |
| 2020-06-30 | $24.59M 10-Q · filed 2021-08-03 | |
| 2020-03-31 | $13.50M 10-Q · filed 2021-05-12 | |
| 2019-12-31 | $16.40M 10-K · filed 2022-02-24 | |
| 2019-09-30 | $21.36M 10-Q · filed 2020-11-10 | |
| 2019-06-30 | $27.37M 10-Q · filed 2020-08-04 | $27.22M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $42.92M 10-Q · filed 2020-05-12 | $42.77M 10-Q · filed 2019-05-14 |
| 2018-12-31 | $23.79M 10-K · filed 2022-02-24 | $23.64M 10-Q · filed 2019-05-14 |
| 2018-09-30 | $25.56M 10-Q · filed 2019-11-05 | |
| 2018-06-30 | $30.46M 10-Q · filed 2019-08-09 | |
| 2018-03-31 | $24.74M 10-Q · filed 2019-05-14 | |
| 2017-12-31 | $38.44M 10-K · filed 2020-03-19 | $38.29M 10-Q · filed 2019-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |